CDMO Education Centre

Advancing Allogeneic CAR T Cell Therapies: Overcoming Challenges in Workflow and Manufacturing

close

Categories

See More

Subscribe to Email Updates

Popular Stories

Developing an Analytical Development Strategy for Immunotherapy Feb 13, 2024
The Canadian Regulatory System for Cell and Gene Therapies Apr 13, 2022
Finding Your Goldilocks: Choosing the Ideal Cell and Gene Therapy CDMO Mar 08, 2024
Understanding Reprogramming of Induced Pluripotent Stem Cells, and Considerations for Use in GMP Manufacturing May 27, 2024
The Vital Role of Process Closure and Automation in CAR T Manufacturing Apr 09, 2024
Categories | Subscribe | Popular
08 Aug 2024

Advancing Allogeneic CAR T Cell Therapies: Overcoming Challenges in Workflow and Manufacturing

Autologous chimeric antigen receptor (CAR) T cell therapies have shown...

09 Apr 2024

The Vital Role of Process Closure and Automation in CAR T Manufacturing

Chimeric antigen receptor (CAR)-based T cell immune therapies are now ...

Tell us what you thought about this post.

You may also like:

Business people meeting around table in modern space

Subscribe to our blog.

Receive updates on the latest trends in cell & gene therapy.

Subscribe to Email Updates

© 2024 All Rights Reserved